Related Experiment Video

Updated: Jan 16, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.6K

SIRT2 puts the brakes on human β cell proliferation: therapeutic opportunities and next challenges

Liora S Katz, Donald K Scott, Andrew F Stewart

    The Journal of Clinical Investigation
    |October 1, 2025
    PubMed

    Insights

    Researchers found that inhibiting sirtuin 2 (SIRT2) can promote the proliferation of pancreatic beta cells. This discovery offers a potential new avenue for regenerative medicine in diabetes treatment.

    Area of Science:

    • Endocrinology
    • Cell Biology
    • Regenerative Medicine

    Background:

    • Diabetes mellitus is characterized by a loss of insulin-producing beta cells.
    • Current therapeutic strategies focus on replacing or regenerating beta cells.

    Purpose of the Study:

    • To investigate the role of sirtuin 2 (SIRT2) in regulating beta cell proliferation.
    • To explore the potential of SIRT2 inhibition for beta cell regeneration.

    Main Methods:

    • Pharmacologic and genetic inhibition of SIRT2 in human and mouse beta cells.
    • Analysis of beta cell proliferation and cell cycle entry.
    • Investigation of SIRT2 targets, including mitochondrial oxidative phosphorylation (OxPhos) enzymes.

    Main Results:

    • SIRT2 acts as a brake on beta cell proliferation.
    • Inhibition of SIRT2 induces human and mouse beta cells to reenter the cell cycle.
    • SIRT2 primarily targets mitochondrial OxPhos enzymes, though the mechanism linking this to cell cycle entry is currently unknown.

    Conclusions:

    • SIRT2 inhibition is a promising strategy for inducing beta cell proliferation.
    • Further research is needed to elucidate the precise mechanism by which SIRT2 affects OxPhos and cell cycle entry.
    • SIRT2 inhibitors represent a potential new class of drugs for beta cell regenerative therapy.

    More Related Videos

    High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds12:32

    High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

    Published on: January 23, 2018

    12.9K
    Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets09:31

    Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

    Published on: June 25, 2012

    14.4K

    Related Concept Videos

    Tissue Renewal without Stem Cells01:23

    Tissue Renewal without Stem Cells

    After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
    However, failure of such a system...
    2.1K
    iPS Cell Differentiation01:22

    iPS Cell Differentiation

    The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
    3.0K
    Glucagon-like Receptor Agonists01:24

    Glucagon-like Receptor Agonists

    Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
    GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
    848
    Insulin: The Receptor and Signaling Pathways01:28

    Insulin: The Receptor and Signaling Pathways

    Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
    2.8K
    Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

    Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

    The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
    Insulin and C-peptide are...
    2.2K
    Somatic to iPS Cell Reprogramming01:29

    Somatic to iPS Cell Reprogramming

    Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
    2.6K